Topical formulations require APIs with controlled particle size and texture for effective skin absorption and formulation stability. Munit supports micronization of topical drug substances under GMP to optimize performance and consistency.
Challenges in Topical API Processing
Particle size in topical APIs affects spreadability, bioavailability, and patient comfort. Oversized or irregular particles can lead to grittiness, poor absorption, or instability in the final formulation.
Munit’s Micronization Capabilities
Using spiral jet mills, we reduce API particles to a narrow, uniform size distribution — ideal for integration into dermal formulations. Our equipment supports low-melting-point substances, moisture-sensitive APIs, and high-potency compounds.
Quality and Regulatory Integration
We provide PSD analytics, batch documentation, and full GMP validation to ensure every batch meets pharmacopeial and internal standards — enabling faster go-to-market for topical products.
Improve consistency and performance in your topical drug.
Partner with Munit for API micronization solutions.